NovaBridge Biosciences
NBPNASDAQHealthcare● Active
$1.62
+$0.06(+3.53%)
Market Cap$186154676
P/E Ratio—
52W High$6.79
52W Low$1.53
NovaBridge Biosciences (NBP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NBP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | ($0.01B) | $0.09B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.05B |
| Gross Profit | $0.00B | $0.00B | $0.00B | ($0.01B) | $0.04B |
| Gross Margin %(computed) | — | — | 100.00% | 100.00% | 47.25% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.16B | $0.11B | $0.16B | $0.19B |
| G&A Expenses | $0.00B | $0.22B | $0.06B | $0.20B | $0.90B |
| Total Operating Expenses | $0.01B | $0.38B | $0.52B | $0.36B | $2.11B |
| Operating Income | ($0.01B) | ($0.38B) | ($0.51B) | ($0.37B) | ($2.07B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.05B | $0.01B | $0.00B | $0.02B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.36B) | ($1.47B) | ($0.97B) | ($2.33B) |
| Income Tax Expense | $0.00B | $0.00B | ($1.26B) | $0.00B | ($0.00B) |
| Net Income | ($0.01B) | ($0.16B) | ($1.47B) | ($2.51B) | ($2.33B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.16 | $-4.46 | $-17.62 | $-30.38 | $-30.70 |
| Wtd Avg Shares | 0.04B | 0.08B | 0.08B | 0.08B | 0.08B |
| EBITDA | ($0.01B) | ($0.37B) | ($0.34B) | ($0.05B) | ($2.06B) |
| EBITDA Margin %(computed) | — | — | — | 478.91% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more NovaBridge Biosciences data
About NovaBridge Biosciences (NBP) Income Statement
NovaBridge Biosciences (NBP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NBP reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.01B) — a net profit margin of —.
Frequently asked questions
NBP · 4 questionsNovaBridge Biosciences (NBP) reported revenue of $0.00B for 2025, down —% year-over-year.
NBP revenueNBP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09